Literature DB >> 4043139

Diazepam: kinetic profiles in various brain areas, plasma and erythrocytes after chronic administration in the rat.

C Hariton, G Jadot, E Mesdjian, P Mandel.   

Abstract

The regional distribution of diazepam (DZP) was established in eleven discrete brain areas in the rat after i.m. chronic treatment (15 days; 5 mg/kg/day). In addition, the kinetic profiles of this drug were investigated in plasma, eryhtrocytes, and three CNS regions (nucleus caudatus, hippocampus, and cerebellum) upon which the pharmacokinetic study was focused. The modifications occuring in plasma-protein binding and erythrocytes binding were reported. In the CNS, the DZP was rapidly distributed; its concentrations and its kinetic profiles were not uniform in the different brain areas studied. The highest amount of DZP was noted in the hypothalamus, while nucleus caudatus and colliculi also presented important DZP levels. Concerning the kinetic parameters after chronic administration, an increase in the elimination half-life time value in central and peripheral compartments, as compared to values reported after acute administration, was observed. The study of cerebral DZP levels as compared with those in the erythrocytes or in plasma suggests a linear correlation in the three CNS areas investigated. These experimental results demonstrate the interest of such studies for psychotropic drug monitoring.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4043139     DOI: 10.1007/BF03189703

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  14 in total

1.  Tissue and erythrocyte distribution of digoxin in infants.

Authors:  R Gorodischer; W J Jusko; S J Yaffe
Journal:  Clin Pharmacol Ther       Date:  1976-03       Impact factor: 6.875

2.  IGPHARM: interactive graphic package for pharmacokinetic analysis.

Authors:  C Gomeni; R Gomeni
Journal:  Comput Biomed Res       Date:  1978-08

3.  Benzodiazepine receptors in rat brain.

Authors:  R F Squires; C Brastrup
Journal:  Nature       Date:  1977-04-21       Impact factor: 49.962

4.  Benzodiasepine and neurotransmitter receptor binding in rat brain after chronic administration of diazepam or phenobarbital.

Authors:  H Möhler; T Okada; S J Enna
Journal:  Brain Res       Date:  1978-11-10       Impact factor: 3.252

5.  Diazepam metabolism during chronic medication unbound fraction in plasma, erythrocytes and urine.

Authors:  I A Zingales
Journal:  J Chromatogr       Date:  1973-01-03

6.  Species difference in diazepam metabolism and anticonvulsant effect.

Authors:  F Marcucci; A Guaitani; J Kvetina; E Mussini; S Garattini
Journal:  Eur J Pharmacol       Date:  1968-11       Impact factor: 4.432

7.  Benzodiazepines: clinical pharmacology and therapeutic use.

Authors:  C Bellantuono; V Reggi; G Tognoni; S Garattini
Journal:  Drugs       Date:  1980-03       Impact factor: 9.546

8.  [Rapid determination of the free plasma fraction of drugs].

Authors:  G Jadot; B Bruguerolle; M Valli; P Bouyard
Journal:  Ann Biol Clin (Paris)       Date:  1980       Impact factor: 0.459

Review 9.  Clinical pharmacokinetics of diazepam.

Authors:  M Mandelli; G Tognoni; S Garattini
Journal:  Clin Pharmacokinet       Date:  1978 Jan-Feb       Impact factor: 6.447

10.  On the interaction of diazepam with human, rat and mouse plasma proteins and erythrocytes.

Authors:  M Láznícek; J Lamka; J Kvĕtina
Journal:  Biochem Pharmacol       Date:  1982-04-01       Impact factor: 5.858

View more
  2 in total

1.  Distribution of diazepam, nordiazepam, and oxazepam between brain extraneuronal space, brain tissue, plasma, and cerebrospinal fluid in diazepam and nordiazepam dependent dogs.

Authors:  E P Wala; W R Martin; J W Sloan
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

2.  Pharmacokinetic-pharmacodynamic modelling of the anticonvulsant effect of oxazepam in individual rats.

Authors:  J Dingemanse; R A Voskuyl; M W Langemeijer; I Postel-Westra; D D Breimer; H Meinardi; M Danhof
Journal:  Br J Pharmacol       Date:  1990-01       Impact factor: 8.739

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.